Press "Enter" to skip to content

 report (2019 – 2024) focuses on market overview, scope of report, share, current market trends and upcoming future predictions. Get Sample PDF Of Report – Biomarkers Market Report Covers Leading Manufacturers: Beckman Coulter Inc. (Danaher Corporation) , Thermo Fisher Scientific Inc. , Abbott Molecular Inc. (Abbott Laboratories Ltd) , Bioporto AS , Astute Medical Inc. , Randox Laborotories Ltd , Siemens Healthcare , Cobo Scientific Biomedical Research , F. Hoffmann,La Roche Ag , BiomerieuxThe Renal Biomarkers Market Overview:The global renal biomarkers market was valued at USD 1,023.04 million in 2018, and is estimated to be valued at USD 1,552.60 million in 2024, witnessing a CAGR of 7.20%. The key factors propelling the growth of this market are the rising prevalence of various kidney-related diseases, the high prevalence of diabetes and high blood pressure, which are the leading causes of renal diseases, and rapid technological advancements in the field of genetics.Advancements in the field of genetic technology during the last decade have enlightened people’s knowledge regarding genetic regulatory pathways related to renal biomarkers. Due to rapid advances in genomic technologies, genetics analyses have become essential in clinical practice and research. Moreover, with the development of computer technology, renal biomarkers testing has become widely accessible and feasible to perform, even in small-sized laboratories. Recent advances in genetics have created opportunities to study kidney disease in a variety of platforms, applied to human populations. Renal biomarkers can also be integrated into genetic-level technological advancements for the detection, diagnosis, and treatment of kidney diseases. These rapid advances in genetics led to the development of more advanced renal biomarkers for treating kidney diseases, which ultimately drives the market.Inquire for further detailed information about Renal Biomarkers Market Report – Biomarker is Expected to hold its Highest Market Share in the Biomarker Type SegmentIn the biomarker type segment of the market, the functional biomarker is believed to have the largest market size and is expected to witness a CAGR of 6.94% during the forecast period.Chronic kidney disease (CKD) has become a public health problem. According to the National Institute of Diabetes, Digestives and Kidney Diseases, the overall prevalence of CKD in the general population is approximately 14%, and around 6,61,000 Americans have kidney failure. Currently, the diagnosis of CKD is made usually on the levels of serum creatinine (SCr). The serum creatinine, a functional biomarker, dominates the market of renal biomarkers, owing to the high prevalence rate of CKD and high presence and knowledge of serum creatinine biomarker.North America Dominates the Market and Expected to do the Same in the Forecast PeriodNorth America currently dominates the market for renal biomarkers and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. Over the past decade, there has been a significant increase in the number of USFDA-approved drug labels containing information on molecular biomarkers. Almost every pharmaceutical company has been developing molecular biomarker programs, either through partnerships or through other ventures. Molecular biomarkers are expected to be identified and validated in drug development and be used to support the approval of drug products. Such drug approvals are helping the renal biomarkers market grow in the United States.The Scope of Renal Biomarkers Market:In the report, a detailed analysis of the global renal biomarkers market is provided. The market is evaluated by collating revenues generated across segments, categorized by biomarker type, diagnostic technique, and end user.Order Full Copy of Report – to Purchase this Report:Current and future of Global Smart Cities Market outlook in the developed and emerging markets • Analysing various perspectives of the market with the help of Porter’s five forces analysis • Report customization as per the client’s requirements • Regions that are expected to witness fastest growth during the forecast period • Identifying the latest developments, market shares and strategies employed by the major market players • 3 month analyst support, along with the Market Estimate sheet (in Excel)About 360 Market Updates:360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.Contact Us:Name: Mr. Ajay MoreEmail: [email protected]Organization: 360 Market UpdatesPhone: +14242530807/+44 203 239 8187Tagged: Google News, Renal Biomarkers Market, Renal Biomarkers Europe Market, Renal Biomarkers APAC Market, Renal Biomarkers Market By Application, Renal Biomarkers Market By Rising Trends, Renal Biomarkers Market Development, Renal Biomarkers Market Forecast, Renal Biomarkers Market Future, Renal Biomarkers Market Growth, Renal Biomarkers Market In Key Countries, Renal Biomarkers Market Latest Report, Renal Biomarkers Market Swot Analysis, Renal Biomarkers Market Top Manufacturers, Renal Biomarkers Sales Market, Renal Biomarkers United States Market